Literature DB >> 26041448

Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats.

Julie O'Neill1, Angelica Fasching2, Liselotte Pihl3, Daniela Patinha3, Stephanie Franzén3, Fredrik Palm4.   

Abstract

Early stage diabetic nephropathy is characterized by glomerular hyperfiltration and reduced renal tissue Po2. Recent observations have indicated that increased tubular Na(+)-glucose linked transport (SGLT) plays a role in the development of diabetes-induced hyperfiltration. The aim of the present study was to determine how inhibition of SLGT impacts upon Po2 in the diabetic rat kidney. Diabetes was induced by streptozotocin in Sprague-Dawley rats 2 wk before experimentation. Renal hemodynamics, excretory function, and renal O2 homeostasis were measured in anesthetized control and diabetic rats during baseline and after acute SGLT inhibition using phlorizin (200 mg/kg ip). Baseline arterial pressure was similar in both groups and unaffected by SGLT inhibition. Diabetic animals displayed reduced baseline Po2 in both the cortex and medulla. SGLT inhibition improved cortical Po2 in the diabetic kidney, whereas it reduced medullary Po2 in both groups. SGLT inhibition reduced Na(+) transport efficiency [tubular Na(+) transport (TNa)/renal O2 consumption (Qo2)] in the control kidney, whereas the already reduced TNa/Qo2 in the diabetic kidney was unaffected by SGLT inhibition. In conclusion, these data demonstrate that when SGLT is inhibited, renal cortex Po2 in the diabetic rat kidney is normalized, which implies that increased proximal tubule transport contributes to the development of hypoxia in the diabetic kidney. The reduction in medullary Po2 in both control and diabetic kidneys during the inhibition of proximal Na(+) reabsorption suggests the redistribution of active Na(+) transport to less efficient nephron segments, such as the medullary thick ascending limb, which results in medullary hypoxia.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  diabetes; oxgen consumption; renal hypoxia; sodium transport; sodium-glucose linked transport

Mesh:

Substances:

Year:  2015        PMID: 26041448     DOI: 10.1152/ajprenal.00689.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  65 in total

Review 1.  Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors.

Authors:  Ralph A DeFronzo; W Brian Reeves; Alaa S Awad
Journal:  Nat Rev Nephrol       Date:  2021-02-05       Impact factor: 28.314

Review 2.  The actions of SGLT2 inhibitors on metabolism, renal function and blood pressure.

Authors:  Merlin C Thomas; David Z I Cherney
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

3.  Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program.

Authors:  Brendon L Neuen; Toshiaki Ohkuma; Bruce Neal; David R Matthews; Dick de Zeeuw; Kenneth W Mahaffey; Greg Fulcher; Qiang Li; Meg Jardine; Richard Oh; Hiddo L Heerspink; Vlado Perkovic
Journal:  J Am Soc Nephrol       Date:  2019-09-17       Impact factor: 10.121

Review 4.  Development of SGLT1 and SGLT2 inhibitors.

Authors:  Timo Rieg; Volker Vallon
Journal:  Diabetologia       Date:  2018-08-22       Impact factor: 10.122

5.  Cardiovascular benefits of SGLT2 inhibition in diabetes and chronic kidney diseases.

Authors:  A T Layton; V Vallon
Journal:  Acta Physiol (Oxf)       Date:  2018-02-22       Impact factor: 6.311

6.  SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolism.

Authors:  Anita T Layton; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2018-01-17

7.  A role for tubular Na+/H+ exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin.

Authors:  Akira Onishi; Yiling Fu; Rohit Patel; Manjula Darshi; Maria Crespo-Masip; Winnie Huang; Panai Song; Brent Freeman; Young Chul Kim; Manoocher Soleimani; Kumar Sharma; Scott Culver Thomson; Volker Vallon
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-07

Review 8.  Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Diabetologia       Date:  2016-11-22       Impact factor: 10.122

Review 9.  Renal Hyperfiltration in Adolescents with Type 2 Diabetes: Physiology, Sex Differences, and Implications for Diabetic Kidney Disease.

Authors:  Petter Bjornstad; David Z Cherney
Journal:  Curr Diab Rep       Date:  2018-03-19       Impact factor: 4.810

Review 10.  Sodium glucose cotransporter 2 inhibition in the diabetic kidney: an update.

Authors:  Aleksandra Novikov; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-01       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.